[HTML][HTML] Epigenetic modulation of antitumor immunity for improved cancer immunotherapy

E Dai, Z Zhu, S Wahed, Z Qu, WJ Storkus, ZS Guo - Molecular cancer, 2021 - Springer
Epigenetic mechanisms play vital roles not only in cancer initiation and progression, but also
in the activation, differentiation and effector function (s) of immune cells. In this review, we …

[HTML][HTML] Breast cancer metastasis: mechanisms and therapeutic implications

M Park, D Kim, S Ko, A Kim, K Mo, H Yoon - International journal of …, 2022 - mdpi.com
Breast cancer is the most common malignancy in women worldwide. Metastasis is the
leading cause of high mortality in most cancers. Although predicting the early stage of breast …

[HTML][HTML] Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets

J Yang, J Xu, W Wang, B Zhang, X Yu… - Signal Transduction and …, 2023 - nature.com
Over decades, researchers have focused on the epigenetic control of DNA-templated
processes. Histone modification, DNA methylation, chromatin remodeling, RNA modification …

[HTML][HTML] Targeting epigenetic regulators to overcome drug resistance in cancers

N Wang, T Ma, B Yu - Signal transduction and targeted therapy, 2023 - nature.com
Drug resistance is mainly responsible for cancer recurrence and poor prognosis. Epigenetic
regulation is a heritable change in gene expressions independent of nucleotide sequence …

[HTML][HTML] A basic review on estrogen receptor signaling pathways in breast cancer

L Clusan, F Ferrière, G Flouriot, F Pakdel - International journal of …, 2023 - mdpi.com
Breast cancer is the most common cancer and the deadliest among women worldwide.
Estrogen signaling is closely associated with hormone-dependent breast cancer (estrogen …

[HTML][HTML] The role of epigenetic modifications in drug resistance and treatment of breast cancer

M Karami Fath, A Azargoonjahromi, A Kiani… - Cellular & Molecular …, 2022 - Springer
Background Breast cancer is defined as a biological and molecular heterogeneous disorder
that originates from breast cells. Genetic predisposition is the most important factor giving …

[HTML][HTML] Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets

F Shu, H Xiao, QN Li, XS Ren, ZG Liu, BW Hu… - … and Targeted Therapy, 2023 - nature.com
Autophagy is a conserved lysosomal degradation pathway where cellular components are
dynamically degraded and re-processed to maintain physical homeostasis. However, the …

[HTML][HTML] ncRNA-mediated ceRNA regulatory network: Transcriptomic insights into breast cancer progression and treatment strategies

S Yang, X Wang, X Zhou, L Hou, J Wu, W Zhang… - Biomedicine & …, 2023 - Elsevier
With the rapid development of next-generation sequencing technology, several studies have
shown that ncRNAs can act as competitive endogenous RNAs (ceRNAs) and are involved in …

[HTML][HTML] Folate-targeted curcumin-loaded niosomes for site-specific delivery in breast cancer treatment: In silico and In vitro study

B Honarvari, S Karimifard, N Akhtari, M Mehrarya… - Molecules, 2022 - mdpi.com
As the most common cancer in women, efforts have been made to develop novel
nanomedicine-based therapeutics for breast cancer. In the present study, the in silico …

[HTML][HTML] Reshaping the tumour immune microenvironment in solid tumours via tumour cell and immune cell DNA methylation: from mechanisms to therapeutics

F Zhong, Y Lin, L Zhao, C Yang, Y Ye… - British Journal of Cancer, 2023 - nature.com
In recent years, the tumour microenvironment (TME) of solid tumours has attracted more and
more attention from researchers, especially those non-tumour components such as immune …